Xofluza Most Promoted Drug in January: Anterio

Shionogi’s novel single-dose flu drug Xofluza (baloxavir marboxil) was the most heavily pitched drug for GPs in the month of January as the influenza season moved into full swing, market research firm Anterio’s “Impact Track” survey showed. The Impact Track...read more